EPO : new GMOs can be differentiated

According to companies, GMO products of genetic modification techniques are patentable because they are considered “inventions”. But to obtain these patents, the European Patent Office (EPO) require from the applicants to be clear about the techniques used for obtaining the organisms or genetic sequences covered by their patent. This obligation shows that, for the EPO, it is possible to differentiate, e.g. between GMOs obtained by patentable mutagenesis techniques on the one hand, and GMOs obtained by other techniques or any other organisms present in nature, on the other hand.

“Essentially biological process”, a definition shaken up

During the parliamentary work on the proposal for a European regulation on plant reproductive material, known as the “seeds regulation”, a question arose: should so-called “non-targeted mutagenesis” be considered as an “essentially biological process”? As these processes are excluded from patentability, the question may seem important. But such a decision would not be without consequences for the regulation of GMOs.

French Anses experts : GMO deregulation has « no scientific basis »

The biotech industry: political pressure

The European Commission wants to put an end to GMOs

Austria attempts to clarify the patentability of living matter

On 20 May 2023, the new Austrian Patent Act came into force. It specifies the exclusions from patentability in the field of plants and animals. One of the aims of these changes is to guarantee a degree of independence for breeders from patent right holders. What will happen in fine?